Sort
261,768 grants matching “gene therapy”
National Gene Vector Biorespository and Coordinating Center at Indiana University
$987,591Kenneth G Cornetta · Indiana University Indianapolis · P40 · FY2008 · RR
Integrative Analysis Core
$987,546Nicholas Joseph Schork · Translational Genomics Research Inst · U19 · FY2025 · AG
Telomeres and Telomerase in Cancer
$987,528Carol W Greider · Johns Hopkins University · R35 · FY2017 · CA
Red Cell Biology
$987,510David M. Bodine · National Human Genome Research Institute · ZIA · FY2019 · HG
Molecular prostheses for mitochondrial disorders
$987,482Vamsi Krishna Mootha · Massachusetts General Hospital · R01 · FY2013 · GM
Improving marginal allograft outcomes through cell junction stabilization in transplantation
$987,481Christina Grek · Xequel Bio, Inc. · R44 · FY2022 · DK
Development and Use of Network Infrastructure for High-Throughput GWA Studies
$987,473Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2008 · HG
SIRT1 in Skeletal Muscle Development, Regeneration, and Atrophy
$987,322Vittorio Sartorelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR
Clinical Studies for Improving Survival Rates for Oral Cancer Patients in Low Resource Settings
$987,292Manijeh N Goldberg · Privo Technologies, Llc · R44 · FY2023 · CA
Ocular Gene Therapy
$987,243Zhijian Wu · National Eye Institute · ZIA · FY2015 · EY
A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
$987,225Gary Fanger · Rise Therapeutics, Llc · R44 · FY2024 · AG
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
$987,185Vikas R. Dharnidharka · Washington University · U01 · FY2023 · CA
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Project 2: Preclinical Model for Antiepileptogenic Therapy Screening in Post-traumatic Epilepsy
$987,181Aristea S Galanopoulou · University Of Southern California · U54 · FY2019 · NS
Telomere Diseases
$987,089Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
$987,088Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Safety and Tolerability Studies for an Anti-Fibrin P2 Monoclonal Antibody for the Treatment of Alzheimer's Disease
$987,080Jeffrey Stavenhagen · Therini Bio, Inc. · U01 · FY2021 · AG
From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
$987,000Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2025 · CA
Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level
$987,000Andrea Califano · Columbia University Health Sciences · R35 · FY2022 · CA
From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
$987,000Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2023 · CA
Chromosomal Proteins and Chromosomal Functions
$986,978Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Extracellular non-coding RNA biomarkers of hepatocellular cancer
$986,936Tushar Patel · Mayo Clinic Jacksonville · UH3 · FY2016 · TR
IND-Enabling Development of HIV Maturation Inhibitors Formulated for use as either Oral or Long-Acting Parenterally Administered Agents
$986,894Carl Wild · Dfh Pharma, Inc. · R44 · FY2025 · AI
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$986,847Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Genetic Susceptibility to Pediatric Glioma inIndividuals and Diverse populations
$986,792Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2016 · CA
Studies of the Natural History of Sickle Cell Disease
$986,763Swee Lay Thein · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL